Skip to main content

GERD: Other Treatment Modalities

  • Chapter
  • First Online:
Foregut Surgery
  • 701 Accesses

Abstract

The treatment of GERD includes diet and lifestyle modifications, medications, and surgery. With emerging concerns regarding the long-term use of PPIs, and the small percentage of patients pursuing Nissen fundoplication (NF), there remains a GERD treatment gap. There are novel endoscopic and laparoscopic techniques that strive to fill this treatment gap for GERD patients. These include Stretta® Endoscopic Radiofrequency Ablation System, transoral incisionless fundoplication (TIF) including Esophyx® and MUSE™, the LINX® Reflux Management System, and EndoStim® LES Stimulation System.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peters JH, DeMeester TR, Crookes P, et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with “typical” symptoms. Ann Surg. 1998;228(1):40–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Funk LM, Kanji A, Scott Melvin W, Perry KA. Elective antireflux surgery in the US: an analysis of national trends in utilization and inpatient outcomes from 2005 to 2010. Surg Endosc. 2014;28(5):1712–9.

    Article  PubMed  Google Scholar 

  3. Streets CG, DeMeester SR, DeMeester TR, et al. Excellent quality of life after Nissen fundoplication depends on successful elimination of reflux symptoms and not the invasiveness of the surgical approach. Ann Thorac Surg. 2002;74(4):1019–25.

    Article  PubMed  Google Scholar 

  4. DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg. 1986;201(1):9–20.

    Article  Google Scholar 

  5. DeMeester TR. Surgical options for the treatment of gastroesophageal reflux disease. Gastroenterol Hepatol. 2017;23(2):128–9.

    Google Scholar 

  6. Nicolau AE, Lobontiu A, Constantinoiu S. New minimally invasive endoscopic and surgical therapies for gastroesophageal reflux disease (GERD). Chirurgia. 2018;113(1):70–82.

    Article  PubMed  Google Scholar 

  7. Papasavas PK, Keenan RJ, Yeaney WW, Caushaj PF, Gagne DJ, Landreneau RJ. Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy. Surg Endosc. 2003;17:1200–5.

    Article  CAS  PubMed  Google Scholar 

  8. Dallemagne B, Weerts J, Markiewicz S, et al. Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc. 2006;20:159–65.

    Article  CAS  PubMed  Google Scholar 

  9. Dallemagne B, Perretta S. Twenty years of laparoscopic fundoplication for GERD. World J Surg. 2011;35(7):1428–35.

    Article  PubMed  Google Scholar 

  10. Hunter JG, Swanstrom L, Waring JP. Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg. 1996;224(1):51–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Robinson B, Dunst CM, Cassera MA, et al. 20 years later: laparoscopic fundoplication durability. Surg Endosc. 2015;29(9):2520–4.

    Article  PubMed  Google Scholar 

  12. Rantanen TK, Salo JA, Salminen JT. Functional outcome after laparoscopic or open Nissen fundoplication: a follow-up study. Arch Surg. 1999;134(3):240–4.

    Article  CAS  PubMed  Google Scholar 

  13. Reavis KM, Nguyen AK. Endolumenal approaches to gastroesophageal reflux disease. SAGES Manual. 2012;2(3):247–60.

    Article  Google Scholar 

  14. Wai-Kit L, Mashimo H. Critical assessment of endoscopic techniques for gastroesophageal reflux disease. J Clin Gastroenterol. 2015;49(9):720–4.

    Article  Google Scholar 

  15. Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron and magnesium. Curr Gastroenterol Rep. 2010;12:448–57.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Janarthanan S, Ditah I, Adler DG, et al. Clostridium Difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107:1001–10.

    Article  CAS  PubMed  Google Scholar 

  17. Filion KB, Chateau D, Targownik LE, et al. Proton pump inhibitors and the risk of hospitalization for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. 2014;63:552–8.

    Article  CAS  PubMed  Google Scholar 

  18. Lo W-K, Chan WW. Proton pump inhibitor use and the risk of mall intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483–90.

    Article  CAS  PubMed  Google Scholar 

  19. Azagury DE. Triadafilopoulos. Minimally invasive GERD therapies. In: Diagnosis and treatment of gastroesophageal reflux disease, vol. 7. Cham: Springer International Publishing; 2016. p. 117–44.

    Chapter  Google Scholar 

  20. Triadafilopoulos G, Azagury D. How can we deal with the GERD treatment gap? Ann N Y Acad Sci. 2016;138(1):14–20.

    Article  Google Scholar 

  21. Mayor MA, Fernando HC. Endoluminal approaches to gastroesophageal reflux disease. Thorac Surg Clin. 2018;28:527–32.

    Article  PubMed  Google Scholar 

  22. Pearl J, Pauli E, Dunkin B, Stefanidis D. SAGES endoluminal treatments for GERD. Surg Endosc. 2017;31:3783–90.

    Article  PubMed  Google Scholar 

  23. Auyang ED, Carter P, Rauth T, Fanelli RD, SAGES Guidelines Committee. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD). Surg Endosc. 2013;27(8):2658–72.

    Article  PubMed  Google Scholar 

  24. Hummel K, Richards W. Endoscopic treatment of gastroesophageal reflux disease. Surg Clin N Am. 2015;95:653–67.

    Article  PubMed  Google Scholar 

  25. Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014;20:7730–8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Richards WO, Scholz S, Khiatan L, et al. Initial experience with the Stretta procedure for the treatment of gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A. 2001;11(5):267–73.

    Article  CAS  PubMed  Google Scholar 

  27. Arts J, Sifrim D, Rutgeerts P, Lerut A, et al. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophageal reflux disease. Dig Dis Sci. 2007;52(9):2170–7.

    Article  CAS  PubMed  Google Scholar 

  28. Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastroesophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30.

    Article  CAS  PubMed  Google Scholar 

  29. Aziz AM, El-Khayat HR, Sadek A, Mattar SG, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(4):818–25.

    Article  PubMed  Google Scholar 

  30. Kim MS, Holloway RH, Dent J, et al. Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs. Gastrointest Endosc. 2003;57(1):17–22.

    Article  PubMed  Google Scholar 

  31. Tam WCE. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut. 2003;52(4):479–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Corley DA, Katz P, Wo JM, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;52(4):479–85.

    Google Scholar 

  33. Galmich JP, des Varannes SB. Endoluminal therapies for gastroesophageal reflux disease. Lancet. 2003;361:1119–21.

    Article  Google Scholar 

  34. DiBaise JK, Brand RE, Quigley EM. Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol. 2002;97:833–42.

    Article  PubMed  Google Scholar 

  35. Yeh RW, Triadafilopoulos G. Endoscopic antireflux therapy: the Stretta procedure. Thorac Surg Clin. 2005;15:395–403.

    Article  PubMed  Google Scholar 

  36. Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002;55(2):149–56.

    Article  PubMed  Google Scholar 

  37. Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130–4.

    Article  CAS  PubMed  Google Scholar 

  38. Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22(4):283–8.

    Article  PubMed  Google Scholar 

  39. Noar M, Squires P, Noara E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28(8):2323–33.

    Article  PubMed  Google Scholar 

  40. Fass R, Cahn F, Scotti DJ, Gregory DA. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease. Surg Endosc. 2017;31(12):4865–82.

    Article  PubMed  Google Scholar 

  41. Mattar SG, Qureshi F, Taylor D, Schauer PR. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc. 2006;20(6):850–4.

    Article  CAS  PubMed  Google Scholar 

  42. Noar M, Squires P, Khan S. Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort. Surg Endosc. 2017;31(7):2854–62.

    Article  PubMed  Google Scholar 

  43. McClusky DA, Khaitan L, Swafford VA, Smith CD. Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) in patients with recurrent reflux after antireflux surgery: can surgery be avoided? Surg Endosc. 2007;21(7):1207–11.

    Article  PubMed  Google Scholar 

  44. Hu ZW, Wang ZG, Shang Y, et al. A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma. Ann Surg Innov Res. 2014;8:3.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Liu DC, Somme S, Mavrelis PG, et al. Stretta as the initial antireflux procedure in children. J Pediatr Surg. 2005;40(1):1448–51.

    Article  Google Scholar 

  46. Islam S, Geiger JD, Coran AG, Teitelbaum DH. Use of radiofrequency ablation of the lower esophageal sphincter to treat recurrent gastroesophageal reflux disease. J Pediatr Surg. 2004;39(3):282–6.

    Article  PubMed  Google Scholar 

  47. Nicolau AE, Lobontiu A, Constantinescu G. Endoluminal fundoplication (ELF) with EsophyX2 for gastroesophageal reflux disease (GERD). Chirurgia. 2009;104(4):381–7.

    CAS  PubMed  Google Scholar 

  48. Jobe BA, O’Rourke RW, McMahon BP, et al. Transoral endoscopic fundoplication the the treatment of gastroesophageal reflux disease. The anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008;248(1):69–76.

    Article  PubMed  Google Scholar 

  49. Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, et al. Efficacy of transoral fundoplication vs omeprazole for the treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33.

    Article  CAS  PubMed  Google Scholar 

  50. Trad KS, Barnes WE, Simoni G, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22(1):26–40.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Trad KS, Fox MA, Simoni G, et al. Transoral fundoplication offers durable symptom control for chronic GERD: 3 year report from the TEMPO randomized trial with crossover arm. Surg Endosc. 2017;31(6):2498–508.

    Article  PubMed  Google Scholar 

  52. Trad KS, Barnes WE, Prevou ER, Simoni G, et al. The TEMPO trial at 5 years: Transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov. 2018;25(2):149–57.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Testoni PA, Testoni S, Mazzoleni G, et al. Long term efficacy of transoral incisionless fundoplication with EsophyX (TIF 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29(9):2770–80.

    Article  PubMed  Google Scholar 

  54. Chimukangara M, Jalilvand AD, Melvin WS, Perry KA. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study. Surg Endosc. 2019;33:1304–9.

    Article  PubMed  Google Scholar 

  55. Huang X, Chen S, Zhao H, et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc. 2017;31(3):1032–44.

    Article  PubMed  Google Scholar 

  56. Gerson L, Stouch B, Lobontiu A. Transoral incisionless fundoplication (TIF 2.0): a meta-analysis of three randomized controlled clinical trials. Chirurgia. 2018;113(2):173–84.

    Article  PubMed  Google Scholar 

  57. Bell RC, Kurian AA, Freeman KD. Revision of failed traditional fundoplication using EsophyX transoral fundoplication. Surg Endosc. 2013;27(3):761–7.

    Article  PubMed  Google Scholar 

  58. Bell RC, Kurian AA, Freeman KD. Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective. Surg Endosc. 2015;29(7):1746–52.

    Article  PubMed  Google Scholar 

  59. Perry KA, Linn JG, Eakin JL, Onders RP, Velanovich V, Melvin WS. Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication. J Laparoendosc Adv Surg Tech A. 2013;23(5):456–8.

    Article  PubMed  Google Scholar 

  60. Chen S, Jarobe MD, Teitelbaum DH. Effectiveness of transluminal endoscopic fundoplication for the treatment of pediatric gastroesophageal reflux disease. Pediatr Surg Int. 2012;28(3):229–34.

    Article  PubMed  Google Scholar 

  61. Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Stapler (MUSE™) for gastroesophageal reflux disease: 6 month results form a multi-center prospective trial. Surg Endosc. 2015;29:220–9.

    Article  PubMed  Google Scholar 

  62. Kauer WK, Roy-Shapira A, Watson D, et al. Preclinical trial of a modified gastroscope that performs a true anterior fundoplication for the endoluminal treatment of gastroesophageal reflux disease. Surg Endosc. 2009;23(12):2728–31.

    Article  PubMed  Google Scholar 

  63. Roy-Shapira A, Bapaye A, Date S, et al. Tran-oral anterior fundoplication: 5-year follow-up of pilot study. Surg Endosc. 2015;29(12):3717–21.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kim HJ, Kown CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device. Surg Endosc. 2016;30:3402–8.

    Article  PubMed  Google Scholar 

  65. Testoni PA, Mazzoleni G, Testoni SG. Transoral incisionless fundoplication for gastro-esophageal reflux disease: techniques and outcomes. World J Gastrointest Pharmacol Ther. 2016;7(2):179–89.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Azagury D, Morton J. Surgical anti-reflux options beyond fundoplication. Curr Gastroenterol Rep. 2017;19(7):35, 1–4.

    Article  PubMed  Google Scholar 

  67. Zak Y, Rattner DW. The use of LINX for gastroesophagel reflux. Adv Surg. 2016;50:41–8.

    Article  PubMed  Google Scholar 

  68. Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(8):719–27.

    Article  CAS  PubMed  Google Scholar 

  69. Kethman W, Hawn M. New approaches to gastroesophageal reflux disease. J Gastrointest Surg. 2017;21(9):1544–52.

    Article  PubMed  Google Scholar 

  70. Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one and 2-year results of a feasibility trial. Ann Surg. 2010;252(5):857–62.

    Article  PubMed  Google Scholar 

  71. Tatum JM, Alicuben E, Bildzukewicz N, Samakar K, Houghton CC, Lipham JC. Minimal versus obligatory dissection of the diaphragmatic hiatus during magnetic sphincter augmentation surgery. Surg Endosc. 2019;33:782–8.

    Article  PubMed  Google Scholar 

  72. Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA. Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech A. 2015;25(10):787–92.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol. 2016;14(5):671–7.

    Article  PubMed  Google Scholar 

  74. Louie BE, Smith CD, Smith CC, et al. Objective evidence of reflux control after magnetic sphincter augmentation: one year results from a post approval study. Ann Surg. 2019;270:302–8.

    Article  PubMed  Google Scholar 

  75. Lipham JC, Taiganides PA, Louie BE, Ganz RA, DeMeester TR. Safety analysis of the first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015;28(4):305–11.

    Article  CAS  PubMed  Google Scholar 

  76. Smith CD, Ganz RA, Lipham JC, Bell RC, Rattner DW. Lower esophageal sphincter augmentation for gastroesophageal reflux disease: the safety of a modern implant. J Laparoendosc Adv Surg Tech A. 2017;27(6):586–91.

    Article  PubMed  Google Scholar 

  77. Alicuben ET, Bell RCW, Jobe BA, Buckley FB 3rd, Daniel Smith C, Graybeal CJ, Lipham JC. Worldwide experience with erosion of the magnetic sphincter augmentation device. J Gastrointest Surg. 2018;22(8):1442–7.

    Article  PubMed  Google Scholar 

  78. Asti E, Siboni S, Lazzari V, Boniita G, Sironi A, Bonavina L. Removal of the magnetic sphincter augmentation device. Ann Surg. 2016;265:941–5.

    Article  Google Scholar 

  79. Chen MY, Huang DY, Wu A, et al. Efficacy of magnetic sphincter augmentation versus nissen fundoplication for gastroesophageal reflux disease in short term: a meta-analysis. Can J Gastroenterol Hepatol. 2017;2017:1–7.

    Google Scholar 

  80. Skubleny D, Switzer NJ, Dang J, Gill RS, Shi X, et al. LINX® magnetic esophageal sphincter augmentation versus nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis. Surg Endosc. 2017;31(8):3078–84.

    Article  PubMed  Google Scholar 

  81. Bell R, Lipham J, Louie B, Williams V, et al. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate to severe regurgitation in GERD: a randomized controlled trial. Gastrointest Endosc. 2019;89:14–22.e1.

    Article  PubMed  Google Scholar 

  82. Hawasli A, Taraki M, Tarboush M. Laparoscopic management of severe reflux after sleeve gastrectomy using the LINX® system: technique and one year follow up case report. Int J Surg Case Rep. 2017;30:148–51.

    Article  PubMed  Google Scholar 

  83. Rona KA, Reynolds J, Schwameis K, et al. Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc. 2017;31(5):2096–102.

    Article  PubMed  Google Scholar 

  84. Buckley FP 3rd, Bell RCW, Freeman K, et al. Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc. 2018;32(4):1762–8.

    Article  PubMed  Google Scholar 

  85. Tatum JM, Lipham JC. Extraluminal approaches to gastroesophageal reflux disease. Thorac Surg Clin. 2018;28(4):521–6.

    Article  PubMed  Google Scholar 

  86. Crowell MD. Implanted electrical devices and gastroesophageal reflux disease: an effective approach to treatment. Expert Rev Gastroenterol Hepatol. 2013;7(3):189–91.

    Article  CAS  PubMed  Google Scholar 

  87. An investigation of the EndoStim Lower Esophageal Sphincter (LES) stimulation system for the treatment of reflux (LESS GERD). ClnicalTrials.gov Identifier: NCT02749071.

  88. Hoppo T, Rodriguez L, Soffer E, Crowell MD, Jobe BA. Long-term results of electrical stimulation of the lower esophageal sphincter for treatment of proximal GERD. Surg Endosc. 2014;28(12):3293–301.

    Article  PubMed  Google Scholar 

  89. Kappelle WF, Bredenoord AJ, Conchillo JM, Ruurda JP, et al. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease- interim results of an international multicenter trial. Aliment Pharmacol Ther. 2015;42(5):614–25.

    Article  CAS  PubMed  Google Scholar 

  90. Rodriguez L, Rodriguez P, Gomez B, et al. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease. Surgery. 2015;157(3):556–67.

    Article  PubMed  Google Scholar 

  91. Soffer E, Rodriguez L, Rodriguez P, Gomez B, et al. Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors. World J Gastrointest Pharmacol Ther. 2016;7(1):145–55.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Rodriguez L, Rodriguez PA, Gomez B, et al. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long term 3-year results. Surg Endosc. 2016;30(7):2666–72.

    Article  PubMed  Google Scholar 

  93. Borbely Y, Bouvy N, Schulz HG, et al. Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(5):611–5.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors have no conflict of interest to declare

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary Hawn .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dorsey, A., Hawn, M. (2020). GERD: Other Treatment Modalities. In: Patti, M., Di Corpo, M., Schlottmann, F. (eds) Foregut Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-27592-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27592-1_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27591-4

  • Online ISBN: 978-3-030-27592-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics